Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.

[1]  R. Krauss.  Effects of progestational agents on serum lipids and lipoproteins. , 1982, The Journal of reproductive medicine.

[2]  V. Wynn,et al.  The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. , 1982, American journal of obstetrics and gynecology.

[3]  R. Krauss,et al.  Regulation of high density lipoprotein levels. , 1982, The Medical clinics of North America.

[4]  P. Wahl,et al.  Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. , 1981, The Journal of clinical endocrinology and metabolism.

[5]  E. Nikkilä,et al.  Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. , 1981, Atherosclerosis.

[6]  M. Pike,et al.  The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol. , 1981, Contraception.

[7]  B. Lewis,et al.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. , 1981, British medical journal.

[8]  M. Briggs.  A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles. , 1981, Contraception.

[9]  L. Wallentin,et al.  Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. , 1981, Fertility and sterility.

[10]  E. Nikkilä,et al.  Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. , 1980, Atherosclerosis.

[11]  D. Mishell,et al.  Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. , 1980, American journal of obstetrics and gynecology.

[12]  E. Nikkilä,et al.  Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo , 1979, FEBS letters.

[13]  R. Krauss,et al.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.

[14]  D. Anderson.  H.D.L. CHOLESTEROL: THE VARIABLE COMPONENTS , 1978, The Lancet.

[15]  F. Lindgren,et al.  High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. , 1978, Atherosclerosis.

[16]  R. Krauss,et al.  Changes in serum high density lipoproteins in women on oral contraceptive drugs. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[17]  J. Albers,et al.  The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. , 1977, The Journal of clinical investigation.

[18]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[19]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[20]  M. Lopes-Virella,et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.

[21]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[22]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[23]  P. Beck.  Contraceptive steroids: modifications of carbohydrate and lipid metabolism. , 1973, Metabolism: clinical and experimental.

[24]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[25]  D. Moore,et al.  Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel. , 1978, American journal of obstetrics and gynecology.